Nomos Pharma Value SPECIAL No. 2: AIFA reform - scenario and next steps

Nomos and Pharma Value have developed a background paper to analyse the AIFA reform defined in recent weeks in the Senate and understand its next steps.

The aim is to offer a tool for the affected interest groups, from patient associations to pharmaceutical companies, via the regions and AIFA staff themselves, to orient themselves on the timing of their ongoing activities.

Nomos and Pharma Value undertake to update the document with legal/institutional news, information and reflections on the basis of forthcoming developments.

Soon, we will also translate it into English.

AIFA meets

On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency

Special Commission Update No. 3 - Towards the reform of the governance of the Italian Medicines Agency and the Single Commission: where are we?

Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,

Towards the reform of governance of the Italian Medicines Agency and the Single Committee

This is our English version of the analysis 'Towards the reform of governance of the Italian Medicines Agency and the Single Committee' produced in collaboration